Added to YB: 2026-03-12
Pitch date: 2026-01-09
CLPT [bullish]
ClearPoint Neuro, Inc.
-31.35%
current return
Author Info
No bio for this author
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$272.3M
Pitch Price
$15.66
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.10
P/E
-10.18
EV/Sales
7.70
Sector
Health Care Equipment and Supplies
Category
growth
ClearPoint Neuro, Inc. - $CLPT
CLPT: MedTech enabling precise neuro drug delivery via MRI-guided surgery (patient asleep vs awake). 60+ pharma partners developing CNS therapies, 20+ indications. Recent IRRAS acquisition adds $500M cranial fluid mgmt market, expands sales team 40+. 2026 rev guide $54-60M (+54% YoY). Path to breakeven 2027. Mgmt targets $300M rev (20K procedures) mid-term, $500M long-term. Risks: UniQure AMT-130 approval uncertain post-FDA pushback, pre-commercial stage, dilution risk. Trading 8x 2026 rev.
Read full article (8 min)